Clinical Trial


Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis


Brief description

To evaluate the efficacy and to compare efficacy and safety of BI 695501 versus Humira in patients with moderate to severe chronic plaque psoriasis.

Keywords

  •   Psoriasis

Sponsored By

Boehringer Ingelheim

Unique Study ID

NCT02850965

Investigators and Research Sites Near You - Found( 3 )

No Investigator Listed

Vir Biotechnology, Inc.
36207, Anniston, Alabama, United States
Distance from Current Trial is 0 miles

No Investigator Listed

AstraZeneca
36207, Anniston, Alabama, United States
Distance from Current Trial is 0 miles

Rohith G. Patel, MD

Suven Life Sciences Limited
36207, Anniston, Alabama, United States
Distance from Current Trial is 0 miles
View All